NuWays AG: Scandinavian Astor Group AB | Rating: BUY

Classification of NuWays AG to Scandinavian Astor Group AB

Company Name:	Scandinavian Astor Group AB
ISIN:	SE0019175274
Reason for the research:	Update
Recommendation:	BUY
from:	31.03.2025
Target price:	SEK 39.00
Target price on sight of:	12 months
Last rating change:
Analyst:	Henry Wendisch

Faster growth as Sweden ramps up defence spending; PT up

Topic: Last Friday, we hosted an investor call with CFO Billström who gave detailed insights into the new mid-term targets and the short-term M&A pipeline. Further, Sweden aims to significantly ramp up defence spending to 3.5% of GDP by 2030. In detail:

New mid-term targets to be mainly stemmed from organic growth. Contrary to our previous assumption, 2/3 of the new mid-term targets announced last week (SEK 2.5bn sales with more than 15% EBITDA margin by FY’28e) should stem from an organic sales CAGR of 20% (incl. the full acquisition of the SEK 500m sales of the short-term M&A pipeline). The scenario of a 30% organic sales CAGR (vs. 44% yoy organic growth in FY’24) would imply 90% of the mid-term target to stem from organic growth alone, meaning that only little M&A (in ‘26, ‘27 and ‘28) would be necessary to achieve the target.

More M&A expected shortly: Following the resolved SEK 150m capital increase, Astor looks at a wellfilled and defence heavy M&A pipeline. Moreover, Astor has moved Airsafe into a new segment called Astor Protect effective 1st April ‘25 and has made place for a fourth, so far unknown segment “Astor X”. For both new segments, we expect new additions soon.

Sweden ramps up defence spending even more. Also last week, Swedish PM Ulf Kristersson announced that the country will provisionally aim to increase defence spending to 3.5% of GDP by 2030. This is a much bigger and faster ramp-up than previously communicated (2.6% in FY’30). According to our calculation, this implies the defence spending FY’2430 CAGR to almost double from 7% to 12%. 

Organic growth estimate raised: Our old FY’28e sales estimate stood at SEK 586m (not including the short-term M&A pipeline) and was based on an organic sales CAGR of 17% (25e-28e). Against the backdrop of the defence spending hike as well as the company’s strong defence exposure, our old estimate seems too conservative. Therefore, we increase our organic growth assumption to an organic sales CAGR of 20% (25e-28e), but also increase our OPEX and CAPEX assumption, which will become necessary to foster that growth.

Therefore we increase our DCF-based PT to SEK 39.00 (old: SEK 30.00) and reiterate our BUY recommendation.

You can download the research here: http://www.more-ir.de/d/32088.pdf
For additional information visit our website: https://www.nuways-ag.com/research-feed

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++